zanamivir has been researched along with Vascular Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aroor, AR; Augenreich, MA; Bender, SB; Burr, K; Foote, CA; Ghiarone, T; Manrique-Acevedo, C; Martinez-Lemus, LA; McMillan, NJ; Morales-Quinones, M; Padilla, J; Power, G; Ramirez-Perez, FI; Smith, JA | 1 |
1 other study(ies) available for zanamivir and Vascular Diseases
| Article | Year |
|---|---|
Neuraminidase inhibition improves endothelial function in diabetic mice.
Topics: Animals; Antiviral Agents; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Endothelial Cells; Enzyme Inhibitors; Humans; Mice; Neuraminidase; Vascular Diseases; Zanamivir | 2023 |